<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Infective endocarditis in children
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Infective endocarditis in children
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Infective endocarditis in children
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sharon E O'Brien, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David R Fulton, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 22, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infective endocarditis (IE) is an infection of the endocardium and/or heart valves that involves thrombus formation (vegetation), which may damage the endocardial tissue and/or valves. The process can involve native endocardium/endothelium or prosthetic material. Although uncommon in children, it is important to identify and treat IE because of its significant morbidity and mortality. Prompt diagnosis, rapid treatment, and recognition of complications are imperative for optimal patient outcomes.
        </p>
        <p>
         IE is also referred to as bacterial endocarditis because bacteria are the predominant microbial pathogens. IE is used in this review to include both bacterial and fungal endocarditis.
        </p>
        <p>
         Many aspects of IE are similar in children and adults, but there are some manifestations that are unique to children. An overview of IE in children is presented here. A number of other topics address particular issues in detail, some of which will be addressed here for children:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antibiotic prophylaxis of IE (see
         <a class="medical medical_review" href="/z/d/html/2147.html" rel="external">
          "Prevention of endocarditis: Antibiotic prophylaxis and other measures"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antimicrobial therapy for IE (see
         <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">
          "Antimicrobial therapy of left-sided native valve endocarditis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2141.html" rel="external">
          "Antimicrobial therapy of prosthetic valve endocarditis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Complications and outcome of IE (see
         <a class="medical medical_review" href="/z/d/html/2142.html" rel="external">
          "Complications and outcome of infective endocarditis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diagnostic criteria and approach for IE (see
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epidemiology, risk factors and microbiology of IE (see
         <a class="medical medical_review" href="/z/d/html/2151.html" rel="external">
          "Native valve endocarditis: Epidemiology, risk factors, and microbiology"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Role of echocardiography in the diagnosis of IE (see
         <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">
          "Role of echocardiography in infective endocarditis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Surgery for IE (see
         <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">
          "Surgery for left-sided native valve infective endocarditis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2132.html" rel="external">
          "Surgery for prosthetic valve endocarditis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H150807696">
         <span class="h2">
          Incidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reported incidence rates of pediatric IE in the United States range from 0.3 to 3.3 per 100,000 individuals per year [
         <a href="#rid1">
          1,2
         </a>
         ]. Rates are higher among infants &lt;1 year old compared with older children and adolescents. The highest rates are seen in children with congenital heart disease (CHD). In one study, the estimated cumulative risk of IE by age 18 years among children with CHD was 0.6 percent [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         Rates of pediatric IE increased during the latter half of the twentieth century, likely due to dramatic improvements in survival of children with CHD and increased use of central venous catheters (CVC) [
         <a href="#rid4">
          4,5
         </a>
         ]. Since the early 2000s, rates of IE appear to have plateaued or slightly decreased [
         <a href="#rid1">
          1,2,6
         </a>
         ]. Studies evaluating pediatric hospital admission rates for IE in the United States before and after publication of the 2007 revised antibiotic prophylaxis guidelines did not detect a difference between the two eras [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1846287311">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most children with IE have an identifiable risk factor for the disease.
        </p>
        <p class="headingAnchor" id="H32860972">
         <span class="h3">
          Congenital heart disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with CHD, especially those with cyanotic heart disease, are at increased risk of developing IE. Underlying CHD is present in approximately 35 to 60 percent of children with IE [
         <a href="#rid2">
          2,4,6,8-10
         </a>
         ]. The risk of IE is highest in patients with complex cyanotic heart disease, especially in those who have had surgical intervention [
         <a href="#rid3">
          3,8,11-16
         </a>
         ].
        </p>
        <p>
         Reported incidence rates of IE in children with CHD range from 40 to 60 per 100,000 person-years, which is several orders of magnitude higher than in the general pediatric population [
         <a href="#rid3">
          3,17
         </a>
         ]. In these reports, the CHD lesions at highest risk for IE included cyanotic lesions, endocardial cushion defect, left-sided lesions, and ventricular septal defects (VSD). Other risk factors included cardiac surgery within six months and age &lt;3 years.
        </p>
        <p>
         There appears to be an increased risk for IE in patients who undergo transcatheter pulmonary valve replacement (eg, following repair of tetralogy of Fallot); the risk is particularly high with bovine jugular vein prostheses [
         <a href="#rid18">
          18
         </a>
         ]. This issue is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/141526.html" rel="external">
          "Tetralogy of Fallot (TOF): Long-term complications and follow-up after repair", section on 'Pulmonary valve replacement (PVR)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5770.html" rel="external">
          "Tetralogy of Fallot (TOF): Management and outcome"
         </a>
         .)
        </p>
        <p>
         In a study of 3840 pediatric hospital admissions for IE from the Nationwide Inpatient Sample database (2000 to 2010), 54 percent had underlying cardiac conditions, of whom 81 percent had CHD [
         <a href="#rid2">
          2
         </a>
         ]. The most common congenital heart defect was VSD (32 percent). Cyanotic lesions accounted for 25 percent of the CHD cases. A prosthetic valve was present in 7 percent, and other cardiac devices were present in 4 percent.
        </p>
        <p>
         In a similar study of 1588 pediatric hospital admissions for IE from the Kid's Inpatient Database (2000 to 2003), the most common CHD diagnoses were tetralogy of Fallot (20 percent), ventricular septal defect (18 percent), hypoplastic left heart syndrome (10 percent), congenital aortic regurgitation (8 percent), D-transposition of the great arteries (6 percent), and patent ductus arteriosus (5 percent) [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3567589714">
         <span class="h3">
          Central venous catheters
         </span>
         <span class="headingEndMark">
          —
         </span>
         An indwelling CVC is another major risk factor for pediatric IE [
         <a href="#rid19">
          19
         </a>
         ]. At-risk pediatric populations for IE include critically ill and premature infants and children with cancer or connective tissue disorders. The increased use of CVCs in these pediatric groups appears to be a major factor for IE [
         <a href="#rid8">
          8,11,12,19,20
         </a>
         ]. The risk is similarly increased with use of other intracardiac devices (eg, ventriculoatrial shunts, pacemakers, implantable cardioverter-defibrillators, and prosthetic and bioprosthetic valves). In a study of 3840 pediatric hospital admissions for IE (2000 to 2010), 7 percent of patients with underlying cardiac conditions had a prosthetic valve and 4 percent had another cardiac device [
         <a href="#rid2">
          2
         </a>
         ]. As use of these devices becomes more common, the relative proportion of device-related IE increases. (See
         <a class="medical medical_review" href="/z/d/html/3806.html" rel="external">
          "Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/111138.html" rel="external">
          "Hydrocephalus in children: Management and prognosis", section on 'CSF shunt'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3451657650">
         <span class="h3">
          Rheumatic heart disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         In developed countries, the incidence of rheumatic heart disease has declined dramatically since the 1960s, and in the modern era, rheumatic heart disease is an uncommon predisposing condition for IE in children [
         <a href="#rid4">
          4,8
         </a>
         ]. In a study of 3840 pediatric hospital admissions for IE (2000 to 2010), 15 percent of patients with underlying cardiac conditions had rheumatic heart disease [
         <a href="#rid2">
          2
         </a>
         ]. In resource-limited settings, rheumatic heart disease remains an important risk factor. (See
         <a class="medical medical_review" href="/z/d/html/3151.html" rel="external">
          "Acute rheumatic fever: Epidemiology and pathogenesis", section on 'Epidemiology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13612.html" rel="external">
          "Clinical manifestations and diagnosis of rheumatic heart disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3920651904">
         <span class="h3">
          Other risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intravenous drug abuse (associated with right-sided IE) and degenerative heart disease, which are important predisposing factors in the adult population, are less commonly seen in children [
         <a href="#rid4">
          4,21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         IE is the result of a series of complex interactions among blood-borne pathogens, damaged endothelium, fibrin, and platelets [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The endocardial surface is initially injured by shear forces associated with turbulent blood flow in children with congenital heart disease (CHD), or indwelling central venous catheters in children without CHD.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         At the site of endothelial damage, fibrin, platelets, and occasionally red blood cells are deposited and initially form a noninfected thrombus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transient bacteremia (which occurs in normal children) or fungemia results in adherence of microbial pathogens to the injured endocardium and thrombus. Subsequent fibrin and platelet deposition over the infected vegetation result in a protective sheath that isolates the organisms from host defenses and permits rapid proliferation of the infectious agent.
        </p>
        <p>
        </p>
        <p>
         Involvement of other organs is secondary to embolization or immune-mediated processes (eg, glomerulonephritis). (See
         <a class="local">
          'Clinical manifestations'
         </a>
         below and
         <a class="local">
          'Complications'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although a variety of microorganisms can cause IE, staphylococci and streptococci species are the most common pathogens associated with IE in children [
         <a href="#rid2">
          2,8,23
         </a>
         ]. In a large retrospective study that included culture results on &gt;2500 children hospitalized for IE, the relative frequency of different pathogens varied according to whether the child had underlying heart disease [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among children
         <strong>
          with
         </strong>
         underlying heart disease:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          Staphylococcus
         </em>
         <em>
          aureus
         </em>
         – 28 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other
         <em>
          Staphylococcus
         </em>
         species – 7 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Viridans streptococci – 33 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other streptococci – 17 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gram-negative bacilli – 5 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polymicrobial – 11 percent
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among children
         <strong>
          without
         </strong>
         underlying heart disease:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <em>
          S. aureus
         </em>
         – 47 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other
         <em>
          Staphylococcus
         </em>
         species – 6 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Viridans streptococci – 18 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other streptococci – 10 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gram-negative bacilli – 8 percent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polymicrobial – 12 percent
        </p>
        <p>
        </p>
        <p>
         These results demonstrate the relatively high incidence of endocarditis due to
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         , particularly among children without heart disease. IE caused by
         <em>
          S. aureus
         </em>
         is typically an acute fulminant process with a high mortality rate, as compared with IE due to most other pathogens. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         below and
         <a class="local">
          'Outcome'
         </a>
         below.)
        </p>
        <p>
         Although patients with indwelling catheters are at risk for bacteremia with gram-negative organisms, gram-negative bacterial endocarditis is rare. This is probably due to the poor ability of gram-negative bacteria to adhere to the endocardium.
        </p>
        <p>
         In neonates with IE, likely etiologic agents include
         <em>
          S. aureus
         </em>
         , coagulase-negative staphylococci,
         <em>
          Klebsiella pneumonia,
         </em>
         and
         <em>
          Enterobacter
         </em>
         species, among others [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Similar to adults, blood cultures remain negative in 5 to 7 percent of children with IE [
         <a href="#rid4">
          4,21,22,25
         </a>
         ]. Potential mechanisms include previous administration of antimicrobial agents, inadequate microbiologic techniques, or infection with highly fastidious bacteria or nonbacterial pathogen. Consultation with an infectious disease expert is recommended in all cases of culture-negative endocarditis.
        </p>
        <p>
         Fungal endocarditis is rare and is typically caused by
         <em>
          Candida
         </em>
         species [
         <a href="#rid4">
          4
         </a>
         ]. Indwelling catheters and high glucose concentrations in parenteral nutrition have contributed to the occurrence of fungal endocarditis, especially in premature infants [
         <a href="#rid12">
          12
         </a>
         ]. Fungal endocarditis is frequently associated with large, friable vegetations that can embolize, producing important complications. (See
         <a class="local">
          'Complications'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5024.html" rel="external">
          "Clinical manifestations and diagnosis of Candida infection in neonates", section on 'Endocarditis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H387392767">
         <span class="h2">
          Presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical presentation of pediatric IE is variable and depends upon the extent of the local cardiac disease, degree of involvement of other organs (eg, embolization), and the causative agent.
        </p>
        <p>
         IE is generally classified as a subacute or acute process.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Subacute
         </strong>
         — The subacute presentation is characterized by a prolonged course of low-grade fever and nonspecific complaints including fatigue, arthralgias, myalgias, chills, weight loss, exercise intolerance, and diaphoresis. The presence of a cluster of these symptoms in a patient at risk for IE (ie, those with preexisting heart disease or indwelling central venous catheter) should raise the possibility of IE as a potential diagnosis. In addition, there is a risk of immunologic sequelae, such as immune-mediated glomerulonephritis. The less virulent pathogens, such as viridans group streptococci and coagulase-negative staphylococci, are usually the causative agents for subacute IE.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute
         </strong>
         — Acute IE is a rapidly progressive and fulminant disease. These patients typically have high spiking fevers, and appear severely ill. An acute presentation is commonly seen in patients with IE due to
         <em>
          S. aureus
         </em>
         , which can cause rapid destruction of heart valve tissue, abscess formation, embolic phenomena, and a rapidly progressive deterioration in hemodynamic status.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1995836722">
         <span class="h2">
          Clinical findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical findings of IE correspond to the underlying pathologic phenomena of bacteremia/fungemia, valvulitis, immunologic response, and embolization [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptoms associated with bacteremia or fungemia include fever, and vasodilation and tachycardia due to decreased systemic vascular resistance. (See
         <a class="medical medical_review" href="/z/d/html/1597.html" rel="external">
          "Pathophysiology of sepsis", section on 'Circulation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Valvulitis may result in a new or changing murmur. In some patients, tachypnea and hypotension are signs of heart failure, which occurs because of perforation of a valve, chordal rupture, or poor ventricular function.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In children with cyanotic congenital heart disease (CHD) with either a systemic-pulmonary shunt or conduit procedure, the murmur may not change, but a decline in systemic oxygen saturation may occur due to obstruction of blood flow.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glomerulonephritis may develop in children who present with subacute IE as a consequence of immune-mediated disease. Other immunologic sequelae (ie, Roth's spots, Janeway lesions, and Osler nodes) are less common in children than they are in adults. These are described in greater detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In children with IE, septic emboli are common, resulting in extracardiac infection (eg, osteomyelitis or pneumonia) or infarction to major vessels and organs. Emboli to the brain may result in neurologic symptoms (eg, seizures, headache, strokes, or altered mental status). Other major organs that may be at risk for embolic episodes include the kidney, gastrointestinal tract, limbs, and lungs. Ophthalmic evaluation might reveal retinal hemorrhagic lesions (Roth spots).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the neonate, the signs and symptoms of IE are variable and nonspecific [
         <a href="#rid26">
          26,27
         </a>
         ]. They include feeding intolerance, tachycardia, respiratory distress, hypotension, and a new or changing murmur. Fever may not be present with either subacute or acute IE. Those with right-sided IE in association with central venous catheters characteristically have little clinical evidence of disease other than persistently positive blood cultures in the setting of appropriate antibiotic treatment [
         <a href="#rid24">
          24
         </a>
         ]. Fungal IE is more common in the newborn infant and may present as an acute fulminant disease [
         <a href="#rid12">
          12
         </a>
         ]. The IE presentation may be indistinguishable from septicemia or heart failure.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2465762713">
         <span class="h2">
          Laboratory findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nonspecific laboratory findings that support the diagnosis of IE include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low hemoglobin/hematocrit demonstrating anemia (either hemolytic or anemia of chronic disease), which is a common feature of IE
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Elevated erythrocyte sedimentation rate and C-reactive protein indicative of inflammation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urinalysis showing hematuria, proteinuria, and red cell casts is suggestive of glomerulonephritis, a minor diagnostic criterion
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3342720069">
         <span class="h2">
          ECG and chest radiograph findings
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Electrocardiography (ECG)
         </strong>
         – ECG is generally not helpful in the diagnosis of IE with the exception of IE with periannular extension, in which prolongation of the PR interval or frank heart block can occur.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chest radiography
         </strong>
         – The chest radiograph is often normal. Nonspecific findings may include cardiomegaly, pulmonary edema, and focal pulmonary infiltrates in patients with pulmonary septic emboli.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of IE is based upon history, physical examination, blood cultures, laboratory tests, and echocardiography.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Blood cultures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Blood cultures are performed in all patients since one of the two major diagnostic criterion is positive blood cultures for typical organisms associated with IE from at least two separate specimens. (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"
         </a>
         .)
        </p>
        <p>
         A minimum of three blood cultures should be obtained over a time period of a few hours to two days depending upon the severity of the illness. In most patients, three blood cultures are obtained from separate venipunctures in the first 24 hours and an additional two blood cultures in the next 24 hours if there is no growth [
         <a href="#rid28">
          28
         </a>
         ]. In critically ill children, three separate venipunctures for blood cultures should be performed as quickly as possible (with &lt;1 hour) and empiric antibiotic therapy started promptly. In children who are not acutely ill, antibiotic therapy can be withheld for at least 48 hours while the blood cultures are collected [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Unless there has been prior antibiotic therapy, more than five blood cultures over two days is generally not warranted. Since bacteremia is generally continuous, the blood cultures do not have to be obtained at any particular time in the fever cycle.
        </p>
        <p>
         It is important to obtain adequate volumes of blood for culture. However, in children, it is often not possible to obtain the large volumes of blood (10 to 20 mL) recommended for adults with suspected IE. In most pediatric settings, the obtained volume of blood for culture is approximately 1 to 3 mL in infants and young children and 5 to 7 mL in older children. If there is a limited volume of blood, preferential culturing of the aerobic culture bottle is suggested because almost all cases of bacterial IE are due to aerobic organisms, and culturing for anaerobes is rarely useful.
        </p>
        <p class="headingAnchor" id="H3425206890">
         <span class="h2">
          Cardiac imaging
         </span>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Echocardiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         An echocardiogram should be performed on all patients in whom there is a reasonable suspicion of IE, as it may detect the presence of a vegetation, a major diagnostic Duke criterion. (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on '2023 Duke-ISCVID criteria'
         </a>
         .)
        </p>
        <p>
         Risk factors for IE including preexisting heart disease, indwelling central lines, presence of prosthetic material, persistent bacteremia, or infection with organisms most associated with IE should prompt early evaluation. Other echocardiographic findings of IE include intracardiac abscess, new or progressive valvular regurgitation, and, in patients with a prosthetic valve, evidence of partial dehiscence.
        </p>
        <p>
         In patients with IE, echocardiography can identify the size and location of a vegetation, extent of valve damage and the degree of valvar stenosis or regurgitation, perivalvar extension of infection, conduit or shunt obstruction, ventricular function, and the presence of a pericardial effusion. It can be used to serially monitor hemodynamic and valvular function, and the resolution of vegetations in response to medical treatment. (See
         <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">
          "Role of echocardiography in infective endocarditis"
         </a>
         .)
        </p>
        <p>
         In most pediatric cases of suspected IE, transthoracic echocardiography (TTE) is adequate to detect the presence of a vegetation, especially in infants and younger children (&lt;10 years and &lt;60 kg), and to monitor hemodynamic and valvular function. TTE is a much more sensitive diagnostic tool in children compared with adults [
         <a href="#rid22">
          22,29,30
         </a>
         ].
        </p>
        <p>
         However, in some children, TTE provides inadequate imaging due to suboptimal echocardiographic windows, which may be circumvented by transesophageal echocardiography (TEE). Inadequate TTE imaging is most likely to occur in the following patients [
         <a href="#rid22">
          22
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Overweight children.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Muscular children.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children with significant respiratory disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children with surgically repaired complex congenital heart disease (CHD), as artifacts from prosthetic material (grafts and conduits) and valves may interfere with TTE imaging [
         <a href="#rid31">
          31
         </a>
         ]. Suboptimal echocardiographic windows are frequently present in the postoperative patient.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children with chest wall disruption from prior surgery or trauma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children with congenital anomalies involving the thoracic cage (eg, severe pectus excavatum).
        </p>
        <p>
        </p>
        <p>
         In addition, in children with aortic valve IE, TEE is superior to TTE for the detection of aortic root abscess. Thus, TEE may be warranted if there are findings on TTE consistent with periannular extension (eg, changing aortic root dimensions) or if there are concerning findings on electrocardiogram (eg, prolonged PR interval or heart block) [
         <a href="#rid28">
          28,32,33
         </a>
         ].
        </p>
        <p>
         Both TTE and TEE may give false-negative results if the vegetations are small or if embolization of the vegetation has occurred. The absence of visible vegetations on echocardiogram does not exclude IE.
        </p>
        <p class="headingAnchor" id="H3768249264">
         <span class="h3">
          Other imaging modalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other imaging modalities such as cardiac magnetic resonance imaging, computed tomography, or cardiac positron emission tomography may be useful in select clinical situations, including when suspicion for endocarditis is high but TTE or TEE have been unrevealing. Additional benefits include the ability to identify distant emboli and early spread of infection prior to anatomic changes. These modalities are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3482797633">
         <span class="h2">
          Diagnostic criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnostic criteria used most commonly for the diagnosis of pediatric IE are the Duke-International Society for Cardiovascular Infectious Disease (ISCVID) criteria, which categorize patients as "definite IE," "possible IE," and "rejected IE" based on pathologic and clinical criteria [
         <a href="#rid34">
          34
         </a>
         ]. These criteria are outlined separately. (See
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on '2023 Duke-ISCVID criteria'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          TREATMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the principles of treatment of IE in children are the same as in adults. In patients with acute IE, blood cultures should be obtained as quickly as possible so appropriate antibiotic therapy can be started. Patients with IE-associated valve dysfunction causing symptomatic heart failure and patients with persistent fevers and bacteremia despite appropriate antibiotic therapy may be candidates for surgical intervention.
        </p>
        <p class="headingAnchor" id="H122012">
         <span class="h2">
          Antibiotic regimens
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antibiotic choice, dose, and duration of treatment are dependent upon the underlying causative microbial agent, and are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2152.html" rel="external">
          "Antimicrobial therapy of left-sided native valve endocarditis"
         </a>
         .)
        </p>
        <p>
         Antibiotic regimens for common bacterial pathogens in pediatric IE are summarized in the tables:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viridans group streptococci and
         <em>
          Streptococcus bovis
         </em>
         (
         <a class="graphic graphic_table graphicRef73007 graphicRef53990 graphicRef61640 graphicRef71412" href="/z/d/graphic/73007.html" rel="external">
          table 1A-D
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enterococci (consultation with an infectious disease specialist is recommended  (
         <a class="graphic graphic_table graphicRef50418" href="/z/d/graphic/50418.html" rel="external">
          table 2
         </a>
         ))
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Staphylococci  (
         <a class="graphic graphic_table graphicRef81429 graphicRef61202" href="/z/d/graphic/81429.html" rel="external">
          table 3A-B
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gram-negative organisms (including
         <em>
          Haemophilus
         </em>
         sp,
         <em>
          Aggregatibacter
         </em>
         sp,
         <em>
          Cardiobacterium hominis
         </em>
         ,
         <em>
          Eikenella corrodens
         </em>
         , and
         <em>
          Kingella
         </em>
         sp [ie, the HACEK group])  (
         <a class="graphic graphic_table graphicRef70411" href="/z/d/graphic/70411.html" rel="external">
          table 4
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         Culture-negative endocarditis (CNE) occurs rarely in children and may be diagnosed when a patient has clinical or echocardiographic evidence of IE but persistently negative blood cultures [
         <a href="#rid28">
          28
         </a>
         ]. Patients with suspected CNE should be managed in consultation with a pediatric infectious disease specialist. Important considerations in determining the treatment regimen include prior antibiotic exposure, route of acquisition of the infection, whether the infection is community acquired or nosocomial, whether the valve infected is native or prosthetic, and whether the infection is acute or subacute [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Surgical intervention
         </span>
         <span class="headingEndMark">
          —
         </span>
         Determination of the need for surgical intervention should be individualized using a multispecialty approach, including involvement of experts in infectious disease, cardiology, and cardiothoracic surgery. Considerations in children are generally similar to those in adults with IE. The most common reasons for surgical intervention include congestive heart failure, progressive valve dysfunction, and embolic phenomena [
         <a href="#rid28">
          28,35,36
         </a>
         ]. Limited pediatric data are available, and clinical practice is largely guided by adult guidelines.
        </p>
        <p>
         Recommendations for surgical intervention in patients with IE are reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">
          "Surgery for left-sided native valve infective endocarditis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3245675632">
         <span class="h1">
          MONITORING
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following tests are helpful in monitoring the patient's clinical course during treatment and after completion of antibiotic therapy:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antimicrobial levels
         </strong>
         – Patients receiving treatment with
         <a class="drug drug_pediatric" data-topicid="13332" href="/z/d/drug information/13332.html" rel="external">
          gentamicin
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">
          vancomycin
         </a>
         should have blood levels for these drugs checked at least once a week. The dose of gentamicin should be adjusted for a target peak level of 3 to 4 mcg/mL and a trough level of &lt;1 mcg/mL, although higher levels may be required for some gram-negative infections [
         <a href="#rid28">
          28
         </a>
         ]. For vancomycin, the target trough level is 10 to 15 mcg/mL, though higher levels (ie, 15 to 20 mcg/mL) may be required initially for methicillin-resistant staphylococci. Children with renal insufficiency require dose adjustments for these agents [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Echocardiography
         </strong>
         – Repeat echocardiogram may be warranted during treatment of IE to assess for changes in vegetations and evaluate valve and myocardial function. This is particularly true of patients exhibiting clinical deterioration, new murmurs, persistent fevers, or bacteremia. Once treatment is completed, repeat evaluation may be necessary to establish a new baseline of valvar and myocardial function for the patient [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Repeat blood cultures
         </strong>
         – Repeat blood cultures are always warranted if there is recurrence of symptoms. Cultures performed after completion of antibiotic therapy may be helpful to demonstrate adequacy of treatment in certain cases (eg, in a patient with
         <em>
          S. aureus
         </em>
         prosthetic valve infection associated with prolonged bacteremia); however, repeat blood cultures may also result in isolation of a contaminant [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          PREVENTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Strategies to prevent IE in children include oral hygiene for prevention of oral disease and antimicrobial prophylaxis for high-risk patients when undergoing invasive procedures [
         <a href="#rid28">
          28
         </a>
         ]. We provide antibiotic prophylaxis in children who are at highest risk for IE based upon guidance from the American Heart Association [
         <a href="#rid38">
          38
         </a>
         ]. Antibiotic IE prophylactic regimens for children are summarized in the table  (
         <a class="graphic graphic_table graphicRef57182" href="/z/d/graphic/57182.html" rel="external">
          table 5
         </a>
         ). Antibiotic prophylaxis for IE is discussed in detail separately, including discussion of patient selection and relevant procedures. (See
         <a class="medical medical_review" href="/z/d/html/2147.html" rel="external">
          "Prevention of endocarditis: Antibiotic prophylaxis and other measures"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          OUTCOME
         </span>
        </p>
        <p class="headingAnchor" id="H3525726904">
         <span class="h2">
          Mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reported mortality rates among children with IE range from 1 to 5 percent [
         <a href="#rid2">
          2,6,8,10
         </a>
         ]. Mortality is highest among patients with underlying cyanotic congenital heart disease (CHD) and with infection caused by
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         [
         <a href="#rid2">
          2,8
         </a>
         ]. In addition, the risk of mortality is increased in patients who develop complications from IE, particularly heart failure, perivalvular abscess, stroke, or septic emboli with distant abscesses.
        </p>
        <p class="headingAnchor" id="H4205194806">
         <span class="h2">
          Complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complications seen in children with IE are generally similar to those seen in adults; however, as a general rule, these complications occur less commonly in children compared with adults.
        </p>
        <p>
         Factors that predispose to the development of complications in children with IE include [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prosthetic cardiac valves
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Left-sided involvement
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          S
         </em>
         .
         <em>
          aureus
         </em>
         or fungal IE
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Previous IE
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prolonged symptoms (≥3 months)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cyanotic congenital heart disease
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Systemic-to-pulmonary shunts
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Poor clinical response to antimicrobial therapy
        </p>
        <p>
        </p>
        <p>
         Complications of IE include cardiac sequelae and end-organ infection or infarction due to embolic events:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac complications
         </strong>
         – Cardiac complications include the following (see
         <a class="medical medical_review" href="/z/d/html/2142.html" rel="external">
          "Complications and outcome of infective endocarditis", section on 'Cardiac complications'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Heart failure – Heart failure can be caused by perforation of the valve, rupture of an infected chordae, or perivalvar leaks or dehiscence in patients with prosthetic valve. Poor ventricular function often accompanies worsening valvar regurgitation. Heart failure is the most common indication for surgical intervention in patients with IE. (See
         <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">
          "Surgery for left-sided native valve infective endocarditis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Perivalvular abscess – Extension of infection beyond the endothelium may result in a fistula tract or perivalvular infection (eg, abscess), which may cause an arrhythmia or atrioventricular heart block. Transesophageal echocardiography (TEE) is more sensitive for detection of myocardial abscess than transthoracic echocardiography (TTE). (See
         <a class="medical medical_review" href="/z/d/html/5323.html" rel="external">
          "Role of echocardiography in infective endocarditis", section on 'Perivalvular abscess or fistula'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Extension of infection into a prosthetic shunt or conduits may occlude the graft. These infections require surgical intervention because they rarely respond to medical management.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Metastatic infection
         </strong>
         – Infection at other sites can occur from septic emboli resulting in osteomyelitis, pneumonia, or distal abscesses in the kidneys, spleen, brain, or soft tissues.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mycotic aneurysms
         </strong>
         – Can occur in any systemic artery and result from septic embolization or, occasionally, from contiguous spread of infection. This complication is usually an indication for surgery.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stroke
         </strong>
         – Stoke occurs in 5 to 15 percent of pediatric IE cases, chiefly in the setting of left-sided IE [
         <a href="#rid2">
          2,10,39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute kidney injury (AKI)
         </strong>
         – AKI can be caused by renal infarction, glomerulonephritis (as a result of an immune-mediated secondary process), and drug-induced acute interstitial nephritis. AKI occurs in approximately 10 percent of pediatric patients with IE [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other embolic events
         </strong>
         , including:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pulmonary embolism (typically occurs in the setting of right-sided IE)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ischemia of the extremities
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Splenic infarction
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Visual impairment (due to embolism or due to endophthalmitis as a result of bacteremic seeding)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute myocardial infarction
        </p>
        <p>
        </p>
        <p>
         The complications of IE are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2142.html" rel="external">
          "Complications and outcome of infective endocarditis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4109137875">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112042.html" rel="external">
          "Society guideline links: Treatment and prevention of infective endocarditis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Incidence
         </strong>
         – Infective endocarditis (IE) is uncommon in children, with an estimated annual incidence of approximately 0.43 per 100,000 per year. Most children with IE have an identifiable risk factor of either preexisting heart disease and/or an indwelling central venous catheter (CVC) or other device. (See
         <a class="local">
          'Incidence'
         </a>
         above and
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         – Streptococci and staphylococci species are the most common pathogens associated with IE in children, although a variety of microorganisms can cause IE. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – The clinical presentation of pediatric IE is variable and is generally classified as either a subacute or acute process. (See
         <a class="local">
          'Presentation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Subacute presentation is characterized by a prolonged course of low-grade fevers and nonspecific complaints, including fatigue, chills, arthralgias, myalgias, weight loss, exercise intolerance, and diaphoresis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Acute IE is a rapidly progressive fulminant disease with high, spiking fevers and an increased likelihood of complications, including hemodynamic instability and heart failure.
         <em>
          Staphylococcus aureus
         </em>
         is the organism most commonly associated with acute IE and carries a higher mortality risk.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Physical findings
         </strong>
         – Physical findings consistent with a diagnosis of IE include a new regurgitant heart murmur and evidence of embolic events. (See
         <a class="local">
          'Clinical findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The clinical diagnosis of IE is made by fulfilling the 2023 Duke-International Society for Cardiovascular Infectious Disease (ISCVID) criteria, which are based upon blood cultures, echocardiogram findings, and other clinical findings. (See
         <a class="local">
          'Diagnosis'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2143.html" rel="external">
          "Clinical manifestations and evaluation of adults with suspected left-sided native valve endocarditis", section on '2023 Duke-ISCVID criteria'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         – The principles of treatment of IE in children are the same as those for adults (see
         <a class="local">
          'Treatment'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Antibiotic therapy
         </strong>
         – The choice, dose, and duration of antibiotic therapy depend upon the underlying causative microbial agent (see
         <a class="local">
          'Antibiotic regimens'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Viridans group streptococci and
         <em>
          Streptococcus bovis
         </em>
         (
         <a class="graphic graphic_table graphicRef73007 graphicRef53990 graphicRef61640 graphicRef71412" href="/z/d/graphic/73007.html" rel="external">
          table 1A-D
         </a>
         )
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Enterococci (consultation with an infectious disease specialist is recommended  (
         <a class="graphic graphic_table graphicRef50418" href="/z/d/graphic/50418.html" rel="external">
          table 2
         </a>
         ))
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Staphylococci  (
         <a class="graphic graphic_table graphicRef81429 graphicRef61202" href="/z/d/graphic/81429.html" rel="external">
          table 3A-B
         </a>
         )
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Gram-negative organisms (including
         <em>
          Haemophilus
         </em>
         sp,
         <em>
          Aggregatibacter
         </em>
         sp,
         <em>
          Cardiobacterium
         </em>
         <em>
          hominis
         </em>
         ,
         <em>
          Eikenella
         </em>
         <em>
          corrodens
         </em>
         , and
         <em>
          Kingella
         </em>
         sp [ie, the HACEK group])  (
         <a class="graphic graphic_table graphicRef70411" href="/z/d/graphic/70411.html" rel="external">
          table 4
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Surgical intervention
         </strong>
         – Determination of the need for surgical intervention should be individualized using a multispecialty approach, including involvement of experts in infectious disease, cardiology, and cardiothoracic surgery. Considerations in children are generally similar to those in adults with IE. (See
         <a class="medical medical_review" href="/z/d/html/2148.html" rel="external">
          "Surgery for left-sided native valve infective endocarditis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention
         </strong>
         – Prophylactic antibiotic therapy for IE  (
         <a class="graphic graphic_table graphicRef57182" href="/z/d/graphic/57182.html" rel="external">
          table 5
         </a>
         ) is reserved for patients with the highest risk of IE, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2147.html" rel="external">
          "Prevention of endocarditis: Antibiotic prophylaxis and other measures"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Outcome
         </strong>
         – The mortality rate for pediatric IE is approximately 1 to 5 percent. Prematurity, cyanotic CHD, and IE due to
         <em>
          S. aureus
         </em>
         are important risk factors for mortality. (See
         <a class="local">
          'Mortality'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Complications of IE include cardiac sequelae (eg, heart failure, perivalvular abscess) and end-organ infection or infarction due to embolic events. (See
         <a class="local">
          'Complications'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2142.html" rel="external">
          "Complications and outcome of infective endocarditis"
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Toyoda N, Chikwe J, Itagaki S, et al. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA 2017; 317:1652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gupta S, Sakhuja A, McGrath E, Asmar B. Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States. Congenit Heart Dis 2017; 12:196.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rushani D, Kaufman JS, Ionescu-Ittu R, et al. Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation 2013; 128:1412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr 1993; 122:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenthal LB, Feja KN, Levasseur SM, et al. The changing epidemiology of pediatric endocarditis at a children's hospital over seven decades. Pediatr Cardiol 2010; 31:813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pasquali SK, He X, Mohamad Z, et al. Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J 2012; 163:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sakai Bizmark R, Chang RR, Tsugawa Y, et al. Impact of AHA's 2007 guideline change on incidence of infective endocarditis in infants and children. Am Heart J 2017; 189:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics of children hospitalized with infective endocarditis. Circulation 2009; 119:865.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marom D, Levy I, Gutwein O, et al. Healthcare-associated versus community-associated infective endocarditis in children. Pediatr Infect Dis J 2011; 30:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ware AL, Tani LY, Weng HY, et al. Resource utilization and outcomes of infective endocarditis in children. J Pediatr 2014; 165:807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rech A, Loss JF, Machado A, Brunetto AL. Infective endocarditis (IE) in children receiving treatment for cancer. Pediatr Blood Cancer 2004; 43:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daher AH, Berkowitz FE. Infective endocarditis in neonates. Clin Pediatr (Phila) 1995; 34:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ashkenazi S, Levy O, Blieden L. Trends of childhood infective endocarditis in Israel with emphasis on children under 2 years of Age. Pediatr Cardiol 1997; 18:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Niwa K, Nakazawa M, Tateno S, et al. Infective endocarditis in congenital heart disease: Japanese national collaboration study. Heart 2005; 91:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodo H, Child JS. Infective endocarditis in congenital heart disease. Cardiol Clin 1996; 14:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris CD, Reller MD, Menashe VD. Thirty-year incidence of infective endocarditis after surgery for congenital heart defect. JAMA 1998; 279:599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sun LC, Lai CC, Wang CY, et al. Risk factors for infective endocarditis in children with congenital heart diseases - A nationwide population-based case control study. Int J Cardiol 2017; 248:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma A, Cote AT, Hosking MCK, Harris KC. A Systematic Review of Infective Endocarditis in Patients With Bovine Jugular Vein Valves Compared With Other Valve Types. JACC Cardiovasc Interv 2017; 10:1449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García-Teresa MA, Casado-Flores J, Delgado Domínguez MA, et al. Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study. Intensive Care Med 2007; 33:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rastogi A, Luken JA, Pildes RS, et al. Endocarditis in neonatal intensive care unit. Pediatr Cardiol 1993; 14:183.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin JM, Neches WH, Wald ER. Infective endocarditis: 35 years of experience at a children's hospital. Clin Infect Dis 1997; 24:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferrieri P, Gewitz MH, Gerber MA, et al. Unique features of infective endocarditis in childhood. Circulation 2002; 105:2115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson JA, Boyce TG, Cetta F, et al. Infective endocarditis in the pediatric patient: a 60-year single-institution review. Mayo Clin Proc 2012; 87:629.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milazzo AS Jr, Li JS. Bacterial endocarditis in infants and children. Pediatr Infect Dis J 2001; 20:799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stockheim JA, Chadwick EG, Kessler S, et al. Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children? Clin Infect Dis 1998; 27:1451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Millard DD, Shulman ST. The changing spectrum of neonatal endocarditis. Clin Perinatol 1988; 15:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oelberg DG, Fisher DJ, Gross DM, et al. Endocarditis in high-risk neonates. Pediatrics 1983; 71:392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baltimore RS, Gewitz M, Baddour LM, et al. Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association. Circulation 2015; 132:1487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kavey RE, Frank DM, Byrum CJ, et al. Two-dimensional echocardiographic assessment of infective endocarditis in children. Am J Dis Child 1983; 137:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Penk JS, Webb CL, Shulman ST, Anderson EJ. Echocardiography in pediatric infective endocarditis. Pediatr Infect Dis J 2011; 30:1109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coward K, Tucker N, Darville T. Infective endocarditis in Arkansan children from 1990 through 2002. Pediatr Infect Dis J 2003; 22:1048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbour SI, Louie EK, O'Keefe JP. Penetration of the atrialventricular septum by spread of infection from aortic valve endocarditis: early diagnosis by transesophageal echocardiography and implications for surgical management. Am Heart J 1996; 132:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karalis DG, Bansal RC, Hauck AJ, et al. Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Clinical and surgical implications. Circulation 1992; 86:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fowler VG, Durack DT, Selton-Suty C, et al. The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis 2023; 77:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amir G, Frenkel G, Rotstein A, et al. Urgent Surgical Treatment of Aortic Endocarditis in Infants and Children. Pediatr Cardiol 2019; 40:580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell HM, Johnson SL, Wurlitzer KC, Backer CL. Outcomes of surgical therapy for infective endocarditis in a pediatric population: a 21-year review. Ann Thorac Surg 2013; 96:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:e57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation 2021; 143:e963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cao GF, Bi Q. Pediatric Infective Endocarditis and Stroke: A 13-Year Single-Center Review. Pediatr Neurol 2019; 90:56.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5768 Version 37.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28444279" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Trends in Infective Endocarditis in California and New York State, 1998-2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27885814" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Trends, microbiology, and outcomes of infective endocarditis in children during 2000-2010 in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24060942" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8501558" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Pediatric infective endocarditis in the modern era.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20414646" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The changing epidemiology of pediatric endocarditis at a children's hospital over seven decades.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22607869" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Trends in endocarditis hospitalizations at US children's hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28625367" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Impact of AHA's 2007 guideline change on incidence of infective endocarditis in infants and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19188508" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Characteristics of children hospitalized with infective endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21289530" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Healthcare-associated versus community-associated infective endocarditis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25064162" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Resource utilization and outcomes of infective endocarditis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15236284" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Infective endocarditis (IE) in children receiving treatment for cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7789013" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Infective endocarditis in neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9326687" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Trends of childhood infective endocarditis in Israel with emphasis on children under 2 years of Age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15894782" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Infective endocarditis in congenital heart disease: Japanese national collaboration study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8853132" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Infective endocarditis in congenital heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9486754" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Thirty-year incidence of infective endocarditis after surgery for congenital heart defect.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28811093" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Risk factors for infective endocarditis in children with congenital heart diseases - A nationwide population-based case control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28728659" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : A Systematic Review of Infective Endocarditis in Patients With Bovine Jugular Vein Valves Compared With Other Valve Types.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17235512" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8415226" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Endocarditis in neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9145742" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Infective endocarditis: 35 years of experience at a children's hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11980694" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Unique features of infective endocarditis in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22766082" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Infective endocarditis in the pediatric patient: a 60-year single-institution review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11734744" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Bacterial endocarditis in infants and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9868659" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3066553" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The changing spectrum of neonatal endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6828346" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Endocarditis in high-risk neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26373317" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6613950" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Two-dimensional echocardiographic assessment of infective endocarditis in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21817953" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Echocardiography in pediatric infective endocarditis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14688563" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Infective endocarditis in Arkansan children from 1990 through 2002.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8969587" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Penetration of the atrialventricular septum by spread of infection from aortic valve endocarditis: early diagnosis by transesophageal echocardiography and implications for surgical management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1638704" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Transesophageal echocardiographic recognition of subaortic complications in aortic valve endocarditis. Clinical and surgical implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37138445" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30604277" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Urgent Surgical Treatment of Aortic Endocarditis in Infants and Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23602067" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Outcomes of surgical therapy for infective endocarditis in a pediatric population: a 21-year review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24603191" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33853363" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30420107" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Pediatric Infective Endocarditis and Stroke: A 13-Year Single-Center Review.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
